Breaking News
Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens
Zymeworks Inc. (NASDAQ: ZYME), a Canada-based clinical-stage biotechnology company, on Monday reported a wider net loss for the fourth quarter...